tolbutamide has been researched along with c-peptide in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (51.39) | 18.7374 |
1990's | 28 (38.89) | 18.2507 |
2000's | 6 (8.33) | 29.6817 |
2010's | 1 (1.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alford, FP; Chisholm, DJ; Larkins, RG; Martin, FI | 1 |
De Nutte, N; De Vroede, M; Gepts, W; Pipeleers, D; Somers, G | 1 |
Dimitriadis, G; Moulopoulos, S; Raptis, S; Zoupas, C | 1 |
Blickle, F; Demangeat, C; Hasselmann, M; Imler, M; Schlienger, JL | 1 |
Beyer, J; Cordes, U; Krause, U | 1 |
Bosquet, F; Cesselin, F; Champigneulle, A; Grimaldi, A; Khalifa, L; Sachon, C; Troupel, S | 1 |
Creutzfeldt, W; Nauck, MA; Siegel, EG | 1 |
Brandhorst, H; Bretzel, RG; Federlin, K; Hering, BJ; Hopt, UT; Hufnagel, B; Klitscher, D; Mellert, J; Pfeffer, F | 1 |
Bergman, RN; Blackwell, J; Dunn, J; Haffner, SM; Mobley, M; Stern, MP | 1 |
Borisova, AM; Kirilov, G; Koev, D | 3 |
Bertrand, J; Demidem, A; Durand, A; Haftek, M; Thivolet, CH | 1 |
van Koetsveld, PM; Verschoor, L; Weber, RF; Weeks, L; Wolffenbuttel, BH | 1 |
Borisova, AM; Kirilov, G; Koev, D; Zlatareva, N | 1 |
Carlo Stella, C; De Caro, L; Ghizzi, A; Gorini, M | 1 |
Kurihara, Y | 1 |
Ikeda, T; Mashiba, H; Mokuda, O; Murakami, I; Tominaga, M | 1 |
Burden, AC; Kinghorn, HA; Samanta, A | 1 |
Borisova, AM; Kirilov, G; Ovcharova, N | 1 |
Joffe, BI; Seftel, HC; Shires, R | 1 |
Baty, J; Dow, RJ; Isles, TE | 1 |
Besch, W; Heinke, P; Ratzmann, KP; Schulz, B | 1 |
Godsland, IF; Jacobs, HS; Seed, M; Wynn, V | 1 |
Burke, MD | 1 |
Fukushima, H; Kitoh, M; Konno, T; Takemiya, M; Uzawa, H; Yamaguchi, K | 1 |
Beuscart, R; Fossati, P; Fourlinnie, JC; Romon, M; Vaast, D; Vie, MC; Wemeau, JL | 1 |
Beuscart, R; Coequyt, S; Vergnes, R; Vie, MC; Wemeau, JL | 1 |
Beischer, W; Heinze, E; Teller, W; Thon, A; Vetter, U | 1 |
Kobayashi, T; Nihei, J; Ohneda, A; Sakai, T | 1 |
Frankel, BJ; Freedman, ZR; Fujiya, H; Grodsky, GM; Karam, JH; Lewitt, PA; Nowlain, RE; Young, CW | 1 |
Brennan, MD; Carpenter, AM; Edis, AJ; Rubenstein, AH; Service, FJ | 1 |
Ginsberg-Fellner, F; Horwitz, DL; Mirel, RD; Rayfield, EJ | 1 |
Kumahara, Y; Matsuyama, T; Sawazaki, N; Shima, K; Tanaka, R; Yanaihara, N | 1 |
Dellenbach, P; Goettenberg, N; Schlienger, JL | 1 |
Kallio, H; Karonen, SL; Pelkonen, R; Suoranta, H | 1 |
Moulin, JP; Vague, P | 1 |
Cowett, RM; Rubenstein, AH; Schwartz, R; Susa, JB; Widness, JA; Zeller, WP | 1 |
Groop, L; Tötterman, KJ | 1 |
Damsgaard, EM; Faber, O; Frøland, A; Iversen, S | 1 |
Bohannon, NV; Grodsky, GM; Karam, JH; Lorenzi, M | 1 |
Dreyer, M; Kühnau, J; Rüdiger, HW | 1 |
Horswill, CA; Kien, CL; McCoy, KS; O'Dorisio, T; Zipf, WB | 1 |
Appel, S; Hitzenberger, G; Kalafsky, G; Kallay, Z; Kutz, K; Rüfenacht, T; Tetzloff, W | 1 |
Hinds, A; Parsons, HG; Sheehan, AG | 1 |
Christensen, NJ; Christiansen, E; Madsbad, S; Pedersen, O; Rasmussen, K; Tibell, A; Tydén, G; Võlund, A | 1 |
Boyle, PJ; Justice, KM; Krentz, AJ; Schade, DS; Wright, AD | 1 |
Christiansen, E; Madsbad, S; Rasmussen, K; Tibell, A; Tydén, G | 1 |
Bergman, RN; Harry, DS; Kruszynska, YT; McIntyre, N | 1 |
Giacca, A; Groenewoud, Y; Lewis, GF; Vranic, M; Zinman, B | 1 |
Hara, T; Hotta, N; Koh, N; Nakamura, J; Sakakibara, F; Takeuchi, N | 1 |
Bedford, C; George, E; Hardisty, CA; Harris, N; Heller, SR; Macdonald, IA; Peacey, SR; Rostami-Hodjegan, A; Tucker, GT | 1 |
Cottrell, DA | 1 |
Ader, M; Bergman, RN; Rebrin, K; Steil, G; Watanabe, R | 1 |
Bijlstra, PJ; Lutterman, JA; Russel, FG; Smits, P; Thien, T | 1 |
Clausen, JO; Echwald, SM; Hansen, L; Hansen, T; Pedersen, O; Urhammer, SA | 1 |
Giacca, A; Lewis, GF; Vranic, M | 1 |
George, E; Heller, SR; Peacey, SR; Rostami-Hodjegan, A; Tucker, GT | 2 |
Giacca, A; Harley, P; Lewis, GF; Vranic, M | 1 |
Awata, T; Inoue, I; Katayama, S; Negishi, K; Noji, S; Takahashi, K | 1 |
Chen, YD; Maheux, P; Polonsky, KS; Reaven, GM | 1 |
Cherrington, AD; Edgerton, D; Sindelar, DK | 1 |
Carpentier, A; Giacca, A; Lewis, GF; Vranic, M | 1 |
Bilinski, D; Carpentier, A; Giacca, A; Lewis, GF; Vranic, M | 1 |
Ambye, L; Echwald, SM; Ferrer, J; Grarup, N; Hansen, L; Hansen, T; Pedersen, O | 1 |
Kjems, LL; Madsbad, S; Vølund, A | 1 |
Huopio, H; Komulainen, J; Laakso, M; Niskanen, L; Otonkoski, T; Vauhkonen, I | 1 |
AvRuskin, TW; Juan, CS | 1 |
Huopio, H; Jääskeläinen, J; Kärkkäinen, P; Komulainen, J; Laakso, M; Miettinen, R; Otonkoski, T; Tapanainen, P; Voutilainen, R | 1 |
Assenova, B; Borissova, AM; Kirilov, G; Krivoshiev, S; Tchetirska, M; Vazelov, E | 1 |
Abdel-Wahab, YH; Flatt, PR; McKillop, AM; Ng, MT | 1 |
3 review(s) available for tolbutamide and c-peptide
Article | Year |
---|---|
[ROC analysis: an aid in medical decisions].
Topics: Blood Glucose; C-Peptide; Clinical Competence; Clinical Laboratory Techniques; Diabetes Mellitus; Humans; Statistics as Topic; Tolbutamide | 1983 |
Toward an integrated phenotype in pre-NIDDM.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Liver; Models, Biological; Phenotype; Prediabetic State; Risk Factors; Tolbutamide | 1996 |
The direct and indirect effects of insulin on hepatic glucose production in vivo.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Hypoglycemic Agents; Insulin; Liver; Reference Values; Tolbutamide | 1998 |
10 trial(s) available for tolbutamide and c-peptide
Article | Year |
---|---|
A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.
Topics: Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting; Female; Glyburide; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Random Allocation; Tolbutamide | 1989 |
A comparative study of sulphonylurea and insulin therapy in non insulin dependent diabetics who had failed on diet therapy alone.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diet, Diabetic; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Middle Aged; Tolbutamide | 1987 |
The effect of nicardipine on glucose and drug-stimulated insulin secretion in normal volunteers.
Topics: Adult; Blood Glucose; C-Peptide; Calcium Channel Blockers; Glucose; Humans; Insulin; Insulin Secretion; Male; Nicardipine; Nifedipine; Tolbutamide | 1985 |
Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Propranolol; Random Allocation; Sulfonylurea Compounds; Tolbutamide | 1982 |
Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Random Allocation; Tolbutamide | 1982 |
Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Anticholesteremic Agents; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diclofenac; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Glyburide; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Insulin; Lovastatin; Placebos; Simvastatin; Tolbutamide | 1995 |
Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Kinetics; Male; Middle Aged; Pancreas Transplantation; Tolbutamide | 1994 |
An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibitor in NIDDM.
Topics: Biomarkers; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Energy Intake; Enzyme Inhibitors; Follow-Up Studies; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inpatients; Insulin; Middle Aged; Regression Analysis; Retrospective Studies; Sulfonylurea Compounds; Tolbutamide | 1996 |
Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus.
Topics: Acarbose; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Fasting; Gliclazide; Glucose Intolerance; Glycated Hemoglobin; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Middle Aged; Postprandial Period; Proinsulin; Time Factors; Tolbutamide; Triglycerides; Trisaccharides | 1997 |
L-carnitine consecutively administered to patients on hemodialysis improves beta-cell response.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Carnitine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Islets of Langerhans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; Tolbutamide | 2003 |
59 other study(ies) available for tolbutamide and c-peptide
Article | Year |
---|---|
Relationship between alpha and beta cell function before and after metabolic control in ketotic diabetic subjects.
Topics: Adolescent; Adult; C-Peptide; Diabetic Ketoacidosis; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Tolbutamide | 1978 |
Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
Topics: C-Peptide; Diabetes Complications; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Somatostatin; Streptozocin; Tolbutamide | 1979 |
The use of artificial beta cell in diagnosis and treatment of insulinoma.
Topics: Adenoma, Islet Cell; Adult; Artificial Organs; Blood Glucose; C-Peptide; Feedback; Female; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Monitoring, Physiologic; Pancreatic Neoplasms; Tolbutamide | 1979 |
[Insulin secretion in alcoholic hepatopathy: analysis by measurement of C-peptide (author's transl)].
Topics: Adolescent; Adult; C-Peptide; Fatty Liver, Alcoholic; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Peptides; Tolbutamide | 1978 |
[C-peptide: secretion and metabolism in different functional states and with abnormal B-cell function (author's transl)].
Topics: C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose; Half-Life; Humans; Insulin; Pancreatectomy; Peptides; Tolbutamide | 1977 |
Does glucagon preserve its insulinogenic effect during tolbutamide-induced hypoglycemia?
Topics: Adult; C-Peptide; Glucagon; Humans; Hypoglycemia; Insulin; Tolbutamide | 1992 |
Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Pancreatic Neoplasms; Proinsulin; Tolbutamide | 1991 |
Exchange of pancreata and islets between centers for experimental islet transplantation in the pig.
Topics: Animals; Blood Glucose; C-Peptide; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Pancreas; Pancreatectomy; Swine; Tolbutamide; Transplantation, Autologous | 1991 |
Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.
Topics: Analysis of Variance; Anthropometry; Blood Glucose; C-Peptide; Fasting; Female; Glucose Tolerance Test; Hispanic or Latino; Humans; Insulin; Insulin Secretion; Male; Mexico; Tolbutamide; United States | 1990 |
[High-degree obesity--a risk factor for the development of diabetes mellitus].
Topics: Adolescent; Adult; C-Peptide; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Obesity; Risk Factors; Tolbutamide | 1990 |
Structure, function, and immunogenicity of human insulinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenoma, Islet Cell; Adult; C-Peptide; Fluorescent Antibody Technique; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Insulinoma; Lymphocyte Culture Test, Mixed; Lymphocytes; Microscopy, Electron; Pancreatic Neoplasms; Tolbutamide; Tumor Cells, Cultured | 1988 |
[An improvement in insulin efficacy in patients with type-1 diabetes mellitus following treatment using an insulin infusion pump].
Topics: Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 1; Drug Evaluation; Humans; Insulin; Insulin Infusion Systems; Tolbutamide | 1989 |
[Effect of antihypertensive drugs on insulin secretion and efficacy].
Topics: Adult; Aged; Antihypertensive Agents; C-Peptide; Diabetes Mellitus, Type 2; Drug Evaluation; Drug Interactions; Female; Humans; Hypertension; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Middle Aged; Tolbutamide | 1989 |
[Factors affecting stability in the course of insulin-dependent diabetes mellitus].
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Chronic Disease; Circadian Rhythm; Diabetes Mellitus, Type 1; Female; Humans; Insulin Infusion Systems; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Tolbutamide | 1989 |
[Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
Topics: Adenoma, Islet Cell; Adult; Aged; Blood Glucose; C-Peptide; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulinoma; Male; Middle Aged; Tolbutamide | 1985 |
[Studies on the diagnosis of insulinoma].
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Tolbutamide | 1987 |
Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Tolbutamide | 1988 |
[Insulin secretion and action in acromegaly].
Topics: Acromegaly; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Male; Prolactin; Time Factors; Tolbutamide | 1987 |
Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects.
Topics: Adult; Black or African American; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Obesity; Time Factors; Tolbutamide; White People | 1985 |
Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Drug Synergism; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Insulin Infusion Systems; Male; Middle Aged; Somatostatin; Tolbutamide | 1984 |
The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Hirsutism; Humans; Insulin; Insulin Resistance; Tolbutamide | 1984 |
Hypoglycemia: test strategies for laboratory evaluation.
Topics: Adenoma, Islet Cell; Blood Glucose; C-Peptide; Food; Food Deprivation; Glucose Tolerance Test; Humans; Hypoglycemia; Infant, Newborn; Infant, Newborn, Diseases; Insulin; Radioimmunoassay; Tolbutamide | 1980 |
A case with glucagonoma syndrome--endocrine and metabolic studies.
Topics: Adenoma, Islet Cell; C-Peptide; Endocrine Glands; Female; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Tolbutamide | 1981 |
[Basal C peptide levels in response to intravenous tolbutamide in the detection of incorrect insulin therapy (or prolonged misuse)].
Topics: Adolescent; Adult; Aged; C-Peptide; Diabetes Mellitus; Female; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Peptides; Tolbutamide | 1983 |
The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus.
Topics: Adolescent; Arginine; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucose; Humans; Insulin; Male; Tolbutamide | 1983 |
Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Topics: Adult; Aged; Arginine; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Liver Cirrhosis; Male; Middle Aged; Nephritis; Pancreatic Neoplasms; Peptides; Tolbutamide | 1982 |
Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Diabetic Ketoacidosis; Diabetic Neuropathies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Phenylurea Compounds; Tolbutamide | 1980 |
Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis.
Topics: Blood Chemical Analysis; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperplasia; Hypoglycemia; Insulin; Islets of Langerhans; Middle Aged; Portacaval Shunt, Surgical; Tolbutamide | 1980 |
C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Kinetics; Male; Peptides; Tolbutamide | 1980 |
Failure of exogenous insulin to inhibit C-peptide release from the perfused rat pancreas.
Topics: Animals; Arginine; C-Peptide; Glucagon; Glucose; Insulin; Male; Pancreas; Peptides; Perfusion; Rats; Tolbutamide | 1980 |
[Glucose tolerance on long-term treatment with a progestogen (etynodiol diacetate) (author's transl)].
Topics: Adult; C-Peptide; Ethynodiol Diacetate; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Time Factors; Tolbutamide; Uterine Diseases | 1980 |
Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
Topics: Adult; Blood; Blood Glucose; C-Peptide; Female; Hepatic Veins; Humans; Insulin; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Male; Middle Aged; Peptides; Portal Vein; Tolbutamide; Veins | 1981 |
The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Fasting; Female; Glucose; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Time Factors; Tolbutamide | 1982 |
Permanent neonatal diabetes in an infant of an insulin-dependent mother.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Humans; Infant, Newborn; Insulin; Male; Receptor, Insulin; Tolbutamide | 1982 |
Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Kinetics; Male; Middle Aged; Tolbutamide | 1982 |
Chlorpropamide-alcohol flushing is not useful for individual genetic counseling of diabetic patients.
Topics: Adolescent; Adult; Blushing; C-Peptide; Child; Chlorpropamide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Ethanol; Genetic Counseling; Humans; Middle Aged; Risk; Tolbutamide | 1980 |
Elevated hepatic glucose production in children with cystic fibrosis.
Topics: C-Peptide; Child; Cystic Fibrosis; Fasting; Female; Glucose; Humans; Infusions, Intravenous; Insulin; Liver; Male; Tolbutamide | 1995 |
Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Topics: Administration, Oral; Adolescent; Adult; C-Peptide; Cystic Fibrosis; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Tolbutamide | 1995 |
Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide.
Topics: Adult; Blood Glucose; C-Peptide; Coma; Humans; Hypoglycemia; Male; Octreotide; Tolbutamide | 1993 |
Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT).
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Eating; Fasting; Glucagon; Glycated Hemoglobin; Humans; Islets of Langerhans; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Reference Values; Tolbutamide | 1993 |
Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Liver Cirrhosis; Middle Aged; Tolbutamide | 1993 |
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
Topics: Adult; Algorithms; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Gluconeogenesis; Glucose Clamp Technique; Homeostasis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Liver; Male; Portal System; Reference Values; Tolbutamide | 1996 |
Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cognition; Dose-Response Relationship, Drug; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Hemodynamics; Humans; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin, Regular, Pork; Male; Reaction Time; Recombinant Proteins; Sweating; Tolbutamide; Tremor | 1996 |
Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Female; Food; Glucose Tolerance Test; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Kidney Transplantation; Kinetics; Male; Pancreas Transplantation; Tolbutamide | 1996 |
Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride.
Topics: Adenosine Triphosphate; Adult; Blood Glucose; C-Peptide; Forearm; Humans; Hypoglycemic Agents; Insulin; Male; Potassium Channels; Tolbutamide; Vasodilation | 1996 |
Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM.
Topics: Adenosine Triphosphate; Adult; Blood Glucose; C-Peptide; Cohort Studies; Denmark; Diabetes Mellitus, Type 2; DNA Primers; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Potassium Channels; Potassium Channels, Inwardly Rectifying; Reference Values; Tolbutamide; White People | 1997 |
Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Drug Synergism; Glucagon; Glucose; Humans; Insulin; Liver; Liver Circulation; Male; Tolbutamide | 1997 |
The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Kinetics; Male; Tolbutamide | 1997 |
Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
Topics: Adult; C-Peptide; Cohort Studies; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Heparin; Humans; Hyperinsulinism; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Liver; Male; Time Factors; Tolbutamide; Triglycerides; Tritium | 1997 |
Evidence that insulin can directly inhibit hepatic glucose production.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Metabolic Clearance Rate; Middle Aged; Tolbutamide | 1997 |
Population-based modeling to demonstrate extrapancreatic effects of tolbutamide.
Topics: C-Peptide; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Models, Biological; Population Surveillance; Tolbutamide | 1998 |
Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
Topics: Adult; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Portal System; Tolbutamide | 1999 |
Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucose; Hormones; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Injections, Intravenous; Insulin; Lactic Acid; Male; Portal Vein; Reference Values; Tolbutamide; Veins | 1999 |
Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
Topics: Adult; Aged; Alleles; ATP-Binding Cassette Transporters; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; DNA Mutational Analysis; Female; Gene Frequency; Genetic Variation; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Kinetics; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Potassium Channels; Potassium Channels, Inwardly Rectifying; Promoter Regions, Genetic; Receptors, Drug; Sulfonylurea Receptors; Tolbutamide | 2001 |
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Mathematics; Middle Aged; Models, Biological; Tolbutamide | 2001 |
Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
Topics: Adult; Amino Acid Substitution; ATP-Binding Cassette Transporters; C-Peptide; Female; Genetic Carrier Screening; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mutation, Missense; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors; Tolbutamide | 2002 |
Transient neonatal diabetes mellitus, type 4, type 1 diabetes mellitus, or MODY: which disease is it, anyway?
Topics: Adult; Arginine; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Humans; Infant; Insulin; Insulin Secretion; Islets of Langerhans; Male; Tolbutamide | 2002 |
Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism.
Topics: Adolescent; Adult; C-Peptide; Calcium; Child; Child, Preschool; Diagnosis, Differential; DNA Mutational Analysis; Female; Glucose Tolerance Test; Glycosyltransferases; Humans; Hyperinsulinism; Insulin; Islets of Langerhans; Male; Membrane Proteins; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Potassium Channels, Inwardly Rectifying; Repressor Proteins; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Tolbutamide | 2002 |
Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
Topics: Animals; C-Peptide; Cell Line; Diazoxide; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Rats; Tolbutamide | 2014 |